Stay updated on Ad26.COV2.S Vaccine Study Clinical Trial
Sign up to get notified when there's something new on the Ad26.COV2.S Vaccine Study Clinical Trial page.

Latest updates to the Ad26.COV2.S Vaccine Study Clinical Trial page
- CheckyesterdayChange DetectedLocations section updated to list state-by-state sites (AL, AZ, AR, CA, CO, FL, GA, IL, IN, KS, KY, LA, MD, MA, MI, MN, MS, MO, NV, NJ, NM, NY, NC, OH, OR, PA, SC, TN, TX, UT, WA); the HHS Vulnerability Disclosure link was removed and the page revision is shown as v3.3.3.SummaryDifference1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedThe Publications section now states that entries are automatically filled from PubMed and may not reflect the study, and the revision version is updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check37 days agoChange DetectedDeleted the funding-lapse notice/banner that warned data on the site may not be up to date.SummaryDifference0.1%

- Check51 days agoChange DetectedThe study record shows no modification to core details; the updates appear to be cosmetic in nature (visual/layout tweaks and timestamp changes). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check58 days agoChange DetectedAdded two new study locations in Cali, Colombia (postal codes 760001 and 760032) and removed the previous entry for Santiago de Cali with the same postal codes from the Locations section.SummaryDifference0.3%

- Check80 days agoChange DetectedSummary of changes: updated operating-status notice and a version bump to v3.2.0, replacing the previous v3.1.0.SummaryDifference1.0%

Stay in the know with updates to Ad26.COV2.S Vaccine Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ad26.COV2.S Vaccine Study Clinical Trial page.